J
Josep Mallolas
Researcher at University of Barcelona
Publications - 183
Citations - 7267
Josep Mallolas is an academic researcher from University of Barcelona. The author has contributed to research in topics: Viral load & Hepatitis C virus. The author has an hindex of 41, co-authored 162 publications receiving 6610 citations.
Papers
More filters
Journal ArticleDOI
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients.
Montserrat Laguno,Javier Murillas,José L. Blanco,Esteban Martínez,Rosa Miquel,José Ma. Sanchez-Tapias,Xavier Bargalló,Ángeles García-Criado,Elisa de Lazzari,Maria Larrousse,Agathe León,Montserrat Lonca,Ana Milinkovic,Josep M. Gatell,Josep Mallolas +14 more
TL;DR: PEG-INF +RBV was significantly more effective than INF + RBV for the treatment of chronic hepatitis C in HIV co-infected patients, mainly of genotype 1 or 4.
Journal ArticleDOI
Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy.
Esteban Martínez,José L. Blanco,J.A. Arnaiz,José B. Perez-Cuevas,Amanda Mocroft,Anna Cruceta,Maria Angeles Marcos,Ana Milinkovic,Miguel A. Garcia-Viejo,Josep Mallolas,Xavier Carné,Andrew N. Phillips,Jose M. Gatell +12 more
TL;DR: Hepatotoxicity but not clinical hepatitis was common in HIV-1-infected patients receiving nevirapine-containing regimens and the incidence steadily increased over time.
Journal ArticleDOI
COVID-19 in patients with HIV: clinical case series.
José Luis Santiago Blanco,Juan Ambrosioni,Felipe García,Esteban Martínez,Alex Soriano,Josep Mallolas,José M. Miró +6 more
TL;DR: The first single-centre experience of COVID-19 in patients infected with HIV-1 is described, to the authors' knowledge, including clinical characteristics, antiviral and antiretroviral treatment, and outcomes.
Journal ArticleDOI
Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus
Juan Berenguer,Julio Álvarez-Pellicer,Pilar Miralles Martín,José López-Aldeguer,Miguel Angel Von‐Wichmann,Carmen Quereda,Josep Mallolas,José Sanz,Cristina Tural,José María Bellón,Juan González-García +10 more
TL;DR: It is suggested that the achievement of an SVR after interferon‐ribavirin therapy in patients coinfected with HIV/HCV reduces liver‐related complications and mortality.
Journal ArticleDOI
Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): A non-randomised, open-label trial
Jürgen K. Rockstroh,Mark T. Nelson,Christine Katlama,J. Lalezari,Josep Mallolas,Mark Bloch,Gail V. Matthews,Michael S. Saag,Philippe J. Zamor,Chloe Orkin,Jacqueline Gress,Stephanie O. Klopfer,Melissa Shaughnessy,Janice Wahl,Bach-Yen Nguyen,Eliav Barr,Heather L. Platt,Michael N. Robertson,Mark S. Sulkowski +18 more
TL;DR: This HCV treatment regimen seems to be effective and well tolerated for patients co-infected with HIV with or without cirrhosis, and these data are consistent with previous trials of this regimen in the monoinfected population.